Number of the records: 1
Polymer-ritonavir derivate nanomedicine with pH-sensitive activation possesses potent anti-tumor activity in vivo via inhibition of proteasome and STAT3 signaling
- 1.Sivák, L., Šubr, V., Kovářová, J., Dvořáková, B., Šírová, M., Říhová, B., Randárová, E., Kraus, M., Tomala, J., Studenovský, M., Vondráčková, M., Sedláček, R., Makovický, P., Fučíková, J., Vošahlíková, Š., Spíšek, R., Kostka, L., Etrych, T., Kovář, M. Polymer-ritonavir derivate nanomedicine with pH-sensitive activation possesses potent anti-tumor activity in vivo via inhibition of proteasome and STAT3 signaling. Journal of Controlled Release. 2021, 332(APR 10 2021), 563-580. ISSN 0168-3659. E-ISSN 1873-4995. Available: https://doi.org/10.1016/j.jconrel.2021.03.015.
Number of the records: 1